Literature DB >> 26658600

Age, gender & co-morbidities as risk factors for drug-induced diseases.

Hasan Tahsin Gozdas1, Dilek Arpaci.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26658600      PMCID: PMC4743352          DOI: 10.4103/0971-5916.171297

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


× No keyword cloud information.
Sir, The study by Tandon and colleagues1 on drug-induced diseases (DIDs) is very interesting. However, we have some comments regarding this study. An important portion of the study population was geriatric patients (54%). Also, the number of females was significantly more than males (1.7 vs 1). As stated by Zopf et al2, advanced age and female gender were important risk factors for DIDs. So, these two factors might have significantly affected the results of this study. As seen in Table I, there was a significant difference between the number of patients with single disease and co-morbid conditions (P<0.001). It would be important to know how many patient in this study had diabetes mellitus, chronic renal insufficiency, hepatic insufficiency or AIDS. Because, such co-morbidities cause secondary immune deficiencies and patients having these co-morbidities are more susceptible to adverse effects of immunosuppressive medications such as methotrexate, cyclophosphamide and corticosteroids3.
  3 in total

1.  Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals.

Authors:  Yurdaguel Zopf; Christina Rabe; Antje Neubert; Eckhart G Hahn; Harald Dormann
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 2.  Diseases and drug-related interventions affecting host defence.

Authors:  S de Marie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

3.  Drug-induced diseases (DIDs): An experience of a tertiary care teaching hospital from India.

Authors:  Vishal R Tandon; Vijay Khajuria; Vivek Mahajan; Aman Sharma; Zahid Gillani; Annil Mahajan
Journal:  Indian J Med Res       Date:  2015-07       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.